News from united therapeutics corporation A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Apr 28, 2016, 06:05 ET United Therapeutics Corporation Announces Executive Leadership Changes

 United Therapeutics Corporation (NASDAQ: UTHR) announced today that Roger Jeffs, Ph.D. has stepped down as the company's President and...


Apr 28, 2016, 06:00 ET United Therapeutics Corporation Reports First Quarter 2016 Financial Results

 United Therapeutics Corporation (NASDAQ: UTHR) today announced its financial results for the first quarter ended March 31, 2016. "Our...


Apr 27, 2016, 06:00 ET United Therapeutics Corporation To Present At Deutsche Bank 41st Annual Health Care Conference

 United Therapeutics Corporation (NASDAQ: UTHR) announced today that Martine Rothblatt, Ph.D., Chairman and Co-Chief Executive Officer, of...


Apr 20, 2016, 06:00 ET United Therapeutics Corporation To Announce First Quarter 2016 Financial Results Before Market Open On Thursday, April 28, 2016

 United Therapeutics Corporation (NASDAQ: UTHR) announced today that it will release its first quarter 2016 financial results before market...


Mar 08, 2016, 06:00 ET United Therapeutics Corporation To Present At Barclays Global Healthcare Conference

United Therapeutics Corporation (NASDAQ: UTHR) announced today that Roger Jeffs, Ph.D., President and Co-Chief Executive Officer of United...


Feb 25, 2016, 06:00 ET United Therapeutics Corporation Reports 2015 Fourth Quarter And Annual Financial Results

 United Therapeutics Corporation (NASDAQ: UTHR) today announced its financial results for the fourth quarter and year ended December 31,...


Feb 18, 2016, 20:30 ET United Therapeutics Corporation To Announce Fourth Quarter And Annual 2015 Financial Results Before Market Open On Thursday, February 25, 2016

 United Therapeutics Corporation (NASDAQ: UTHR) announced today that it will release its fourth quarter and annual 2015 financial results...


Feb 18, 2016, 20:00 ET United Therapeutics Receives Paragraph IV Notice Letter For Orenitram

 United Therapeutics Corporation (NASDAQ: UTHR) announced receipt of a Paragraph IV Certification Notice Letter on February 18, 2016 from...


Jan 06, 2016, 06:00 ET United Therapeutics Corporation To Present At 34th Annual J.P. Morgan Healthcare Conference

United Therapeutics Corporation (NASDAQ: UTHR) announced today that Roger Jeffs, Ph.D., President and Co-Chief Executive Officer, of United...


Oct 27, 2015, 06:00 ET United Therapeutics Corporation Reports Third Quarter 2015 Financial Results

 United Therapeutics Corporation (NASDAQ: UTHR) today announced its financial results for the third quarter ended September 30, 2015. "We...


Oct 21, 2015, 06:00 ET United Therapeutics Corporation To Announce Third Quarter 2015 Financial Results Before Market Open On Tuesday, October 27, 2015

 United Therapeutics Corporation (NASDAQ: UTHR) announced today that it will release its third quarter 2015 financial results before market...


Oct 15, 2015, 06:00 ET United Therapeutics Announces Additional $500 Million Share Repurchase Program

 United Therapeutics Corporation (NASDAQ: UTHR) today announced that its Board of Directors authorized the repurchase of up to an additional...


Sep 30, 2015, 06:00 ET United Therapeutics Announces Settlement of Patent Litigation with Sandoz Inc.

 United Therapeutics Corporation (NASDAQ: UTHR) announced today that it has entered into a Settlement Agreement with Sandoz Inc. ("Sandoz")...


Aug 19, 2015, 06:00 ET United Therapeutics Corporation Agrees to Sell Priority Review Voucher to AbbVie for $350 Million

 United Therapeutics Corporation (NASDAQ: UTHR) announced today that it has entered into an agreement to sell its Rare Pediatric Disease...


Aug 17, 2015, 06:00 ET European Commission Grants Marketing Authorisation for Unituxin™ (dinutuximab) for the Treatment of Paediatric High-Risk Neuroblastoma

 United Therapeutics Corporation (NASDAQ: UTHR) announced today that the European Commission (EC) has granted Marketing Authorisation for...


Aug 06, 2015, 06:00 ET United Therapeutics Corporation To Present At The 2015 Wedbush PacGrow Healthcare Conference

 United Therapeutics Corporation (NASDAQ: UTHR) announced today that Martine Rothblatt, Ph.D., Chairman and Co-Chief Executive Officer of...


Jul 28, 2015, 06:00 ET United Therapeutics Corporation Reports Second Quarter 2015 Financial Results

 United Therapeutics Corporation (NASDAQ: UTHR) today announced its financial results for the second quarter ended June 30,...


Jul 22, 2015, 06:00 ET United Therapeutics Corporation To Announce Second Quarter 2015 Financial Results Before Market Open On Tuesday, July 28, 2015

United Therapeutics Corporation (NASDAQ: UTHR) announced today that it will release its second quarter 2015 financial results before market open on...


Jun 29, 2015, 06:00 ET Dean Judy D. Olian Joins the United Therapeutics Corporation Board of Directors

 United Therapeutics Corporation (NASDAQ: UTHR) announced today the appointment of Dean Judy D. Olian, Ph.D. to its Board of Directors as an...


Jun 15, 2015, 09:00 ET United Therapeutics Corporation Receives Paragraph IV Notice Letter for Tyvaso

 United Therapeutics Corporation (NASDAQ: UTHR) today announced receipt of a Paragraph IV Certification Notice Letter from Watson Laboratories,...


May 29, 2015, 06:00 ET United Therapeutics Corporation To Present At The Jefferies 2015 Global Healthcare Conference

United Therapeutics Corporation (NASDAQ: UTHR) announced today that Roger Jeffs, Ph.D., President and Co-Chief Executive Officer of United...


May 01, 2015, 06:00 ET United Therapeutics Corporation To Present At The Deutsche Bank 40th Annual Health Care Conference

 United Therapeutics Corporation (NASDAQ: UTHR) announced today that Roger Jeffs, Ph.D., President and Co-Chief Executive Officer of United...


Apr 28, 2015, 06:00 ET United Therapeutics Corporation Reports First Quarter 2015 Financial Results

United Therapeutics Corporation (NASDAQ: UTHR) today announced its financial results for the first quarter ended March 31, 2015. "Our total...


Apr 21, 2015, 06:00 ET United Therapeutics Corporation To Announce First Quarter 2015 Financial Results Before Market Open On Tuesday, April 28, 2015

United Therapeutics Corporation (NASDAQ: UTHR) announced today that it will release its first quarter 2015 financial results before market open on...


Mar 10, 2015, 11:18 ET United Therapeutics Receives a Rare Pediatric Disease Priority Review Voucher following the Approval of Unituxin™ for Pediatric High-Risk Neuroblastoma

United Therapeutics Corporation (NASDAQ: UTHR) announced today that the United States Food and Drug Administration (FDA), as part of the Biologics...